12-101757311-C-G
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_024312.5(GNPTAB):c.3336-1G>C variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.00000196 in 1,530,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_024312.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GNPTAB | NM_024312.5 | c.3336-1G>C | splice_acceptor_variant, intron_variant | Intron 17 of 20 | ENST00000299314.12 | NP_077288.2 | ||
GNPTAB | XM_011538731.3 | c.3255-1G>C | splice_acceptor_variant, intron_variant | Intron 17 of 20 | XP_011537033.1 | |||
GNPTAB | XM_006719593.4 | c.3336-1G>C | splice_acceptor_variant, intron_variant | Intron 17 of 18 | XP_006719656.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNPTAB | ENST00000299314.12 | c.3336-1G>C | splice_acceptor_variant, intron_variant | Intron 17 of 20 | 1 | NM_024312.5 | ENSP00000299314.7 | |||
GNPTAB | ENST00000550718.1 | c.147-1G>C | splice_acceptor_variant, intron_variant | Intron 2 of 3 | 3 | ENSP00000449557.1 | ||||
GNPTAB | ENST00000549194.1 | n.202-1G>C | splice_acceptor_variant, intron_variant | Intron 2 of 2 | 3 | |||||
GNPTAB | ENST00000549738.5 | n.87-1G>C | splice_acceptor_variant, intron_variant | Intron 1 of 4 | 4 | ENSP00000450161.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152020Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000145 AC: 2AN: 1378002Hom.: 0 Cov.: 23 AF XY: 0.00000145 AC XY: 1AN XY: 690006
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152020Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74238
ClinVar
Submissions by phenotype
Mucolipidosis type II Pathogenic:1Other:1
- -
- -
Pseudo-Hurler polydystrophy;C2673377:Mucolipidosis type II Pathogenic:1
This variant is not present in population databases (ExAC no frequency). Disruption of this splice site has been observed in individuals with mucolipidosis type II and III (PMID: 19617216, 32651481). ClinVar contains an entry for this variant (Variation ID: 41257). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. This sequence change affects an acceptor splice site in intron 17 of the GNPTAB gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in GNPTAB are known to be pathogenic (PMID: 19617216, 25107912). -
Mucolipidosis Pathogenic:1
Variant summary: GNPTAB c.3336-1G>C is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: Two predict the variant abolishes a 5 splicing donor site. Three predict the variant abolishes a 3 acceptor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 247798 control chromosomes (gnomAD). c.3336-1G>C has been reported in the literature in an individual affected with Mucolipidosis Intermediate phenotype (Cathey_2010). To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Another nucleotide change (c.3336-1G>A) in the same position has been noted in the HGMD database. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at